On this page

Healing and pain relief are separate observations

After a procedure, recovery describes the course of healing and functioning. Pain relief describes another outcome. MVD involves recovery from cranial surgery and anaesthesia; percutaneous procedures and radiosurgery have different care pathways. A person's pain status does not alone establish that wound healing or activity recovery is complete.12

Before discharge, request a written plan covering contact routes, wound or treatment-site care, prescribed medicines, follow-up and the activities that need clearance. If treatment took place away from home, clarify which service coordinates later concerns. The reference cannot supply a date for driving, work or flying.

Medicines and follow-up

RCS links postoperative medication management and review to the surgical care pathway. That does not mean every person can immediately stop TN medicine or that a general schedule applies after every procedure. Pain control and tolerability remain questions for the team responsible for prescribing and follow-up.3

At review, describe the pain pattern, daily impact, medicine use and new symptoms since treatment. Ask how the team is judging the result and what uncertainty remains. An account of timing can help a discussion without turning a diary into a diagnostic or medication-adjustment tool.

Warning signs need assessment

Mayfield's cranial-surgery information highlights wound redness or drainage, clear-fluid leakage, increasing headache or vomiting and unusual drowsiness as concerns needing medical contact. New weakness, speech or vision changes, confusion or a seizure need urgent assessment through local emergency care. Use the treating team's discharge contact arrangements; a wiki cannot determine the cause or severity remotely.1

This is general signposting, not a home treatment protocol. Clarify in advance which service to contact for postoperative concerns and how to obtain emergency help locally. Do not wait for the next routine appointment if the discharge instructions or new severe symptoms call for urgent assessment.

Persistent versus returning pain

It is useful to distinguish pain that never fully resolved from pain that returned after a period of relief. Study definitions still matter: a paper reporting pain-free status at its final visit may group several different histories among those not pain-free. Holste's TN review measures BNI I at last follow-up, so the complement of its pain-free proportion cannot be labeled a recurrence rate.4

The five-year Danish study also assesses pain and medication status at follow-up; it is not a time-to-recurrence study. A result at a particular visit differs from the duration of relief after initially successful treatment.5

Repeat treatment requires separate evidence

Worm's MVD cohort excluded previous TN operations. Its outcomes therefore do not supply a repeat-MVD estimate. A repeat-procedure discussion should establish what happened previously, how symptoms changed and which alternatives remain relevant. Prior percutaneous treatment, radiation and decompression are distinct parts of that history.5

NHS information describes the possibility of continued medical care or another procedure when relief is insufficient or pain returns. That range of choices does not determine which is suitable for a reader.2

Ask whether the evidence being discussed concerns first or repeat treatment, the same subtype and pain phenotype, and the same outcome definition. Keep medicine-free pain freedom separate from improvement.

References

  1. Mayfield Brain & Spine. Microvascular decompression (patient information). Source ↩
  2. NHS. Trigeminal neuralgia: treatment. Source ↩
  3. McMillan R et al. Guidelines for the management of trigeminal neuralgia. RCS England Faculty of Dental Surgery, 2021. Source ↩
  4. Holste K, Chan AY, Rolston JD, Englot DJ. Pain outcomes following MVD for drug-resistant TN: systematic review and meta-analysis. Neurosurgery. 2020;86:182–190. Source ↩
  5. Worm J et al. Five-year prospective outcomes of medical management and microvascular decompression in trigeminal neuralgia. J Neurol. 2025. Source ↩